JP2005508321A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508321A5 JP2005508321A5 JP2003530211A JP2003530211A JP2005508321A5 JP 2005508321 A5 JP2005508321 A5 JP 2005508321A5 JP 2003530211 A JP2003530211 A JP 2003530211A JP 2003530211 A JP2003530211 A JP 2003530211A JP 2005508321 A5 JP2005508321 A5 JP 2005508321A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- formula
- volume
- carbapenem
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 9
- 239000007864 aqueous solution Substances 0.000 claims 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 6
- 239000002253 acid Substances 0.000 claims 4
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 claims 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- -1 3-carboxyphenyl Chemical group 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N 2-Butanol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims 2
- JYVLIDXNZAXMDK-UHFFFAOYSA-N 2-Pentanol Chemical compound CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 claims 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butanoic acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 235000011054 acetic acid Nutrition 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 2
- 235000019253 formic acid Nutrition 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N n-pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims 2
- 235000019260 propionic acid Nutrition 0.000 claims 2
- 150000003839 salts Chemical group 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-Hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 claims 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N Isoamyl alcohol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims 1
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N Isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000011167 hydrochloric acid Nutrition 0.000 claims 1
- 229940035429 isobutyl alcohol Drugs 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N t-BuOH Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
Claims (6)
- C1〜5アルコールがメタノール、1−プロパノール、2−プロパノール、イソプロピルアルコール、エタノール、1−ブタノール、2−ブタノール、イソブチルアルコール、t−ブチルアルコール、1−ペンタノール、2−ペンタノール、3−ペンタノール、イソペンチルアルコールおよびこれらの混合物からなる群から選択される請求項2に記載の方法。
- 約−5℃〜約−25℃の温度で実施され、かつ前記酸がギ酸、酢酸、プロピオン酸および酪酸からなる群から選択される請求項2に記載の方法。
- 酸が酢酸である請求項4に記載の方法。
- 式IIa、形態B
a)式IIおよび式4
b)前記溶液を−5℃から−25℃に冷却するステップと、
c)ギ酸、酢酸、プロピオン酸および塩酸からなる群から選択される酸を用いてpHを約6〜約5に調節するステップと、
d)前記水溶液の容積に対して約0.5〜約3.0容積のメタノール、および前記水溶液の容積に対して約0.5〜約3.0容積の1−プロパノールを前記溶液に加えることによって結晶化させるステップと、
e)式IIaの形態Aカルバペネム結晶を単離するステップと、
とを含む方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32512701P | 2001-09-26 | 2001-09-26 | |
PCT/US2002/030002 WO2003026572A2 (en) | 2001-09-26 | 2002-09-20 | Crystalline forms of ertapenem sodium |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005508321A JP2005508321A (ja) | 2005-03-31 |
JP2005508321A5 true JP2005508321A5 (ja) | 2005-12-22 |
Family
ID=23266545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003530211A Pending JP2005508321A (ja) | 2001-09-26 | 2002-09-20 | 結晶形態のエルタペネムナトリウム |
Country Status (6)
Country | Link |
---|---|
US (2) | US7145002B2 (ja) |
EP (1) | EP1442038A4 (ja) |
JP (1) | JP2005508321A (ja) |
AU (1) | AU2002331885B2 (ja) |
CA (1) | CA2457642C (ja) |
WO (1) | WO2003026572A2 (ja) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL218808B1 (pl) * | 2001-09-26 | 2015-01-30 | Merck & Co Inc | Sposób zmniejszania poziomów rozpuszczalników organicznych w stałym karbapenemie |
PL368984A1 (en) * | 2001-11-16 | 2005-04-04 | Ranbaxy Laboratories Limited | Process for the preparation of crystalline imipenem |
AU2004224181B2 (en) * | 2003-03-27 | 2011-06-02 | Basilea Pharmaceutica Ag | Cephalosporin in crystalline form |
US8093378B2 (en) | 2006-04-28 | 2012-01-10 | Kaneka Corporation | Crystallization method for intermediates of carbapenem antibiotics |
EP2045244B1 (en) * | 2006-07-20 | 2013-04-03 | Asahi Kasei Pharma Corporation | Novel crystal of substituted phenylalkanoic acid and production process |
US8293894B2 (en) * | 2006-11-20 | 2012-10-23 | Orchid Chemicals & Pharmaceuticals Limited | Process for the preparation of carbapenem antibiotic |
KR101588466B1 (ko) | 2007-08-22 | 2016-01-25 | 아스트라제네카 아베 | 시클로프로필 아미드 유도체 |
US20110172201A1 (en) * | 2008-06-11 | 2011-07-14 | Ranbaxy Laboratories Limited | Process for preparing a carbapenem antibiotic composition |
CA3013000C (en) | 2008-12-19 | 2022-12-13 | Vertex Pharmaceuticals Incorporated | Pyrazine derivatives useful as inhibitors of atr kinase |
US20110288142A1 (en) * | 2009-01-30 | 2011-11-24 | Chen Pingyun Y | CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride |
TW201039825A (en) | 2009-02-20 | 2010-11-16 | Astrazeneca Ab | Cyclopropyl amide derivatives 983 |
WO2010124531A1 (zh) | 2009-04-30 | 2010-11-04 | 石药集团中奇制药技术(石家庄)有限公司 | 一种厄他培南中间体、含其的组合物及其制备方法 |
NZ602108A (en) * | 2010-02-18 | 2014-09-26 | Astrazeneca Ab | Solid forms comprising a cyclopropyl amide derivative |
MX2012009473A (es) | 2010-02-18 | 2012-09-12 | Astrazeneca Ab | Procesos para preparar derivados de ciclopropilamidas e intermedios asociados con estas. |
SG185524A1 (en) | 2010-05-12 | 2012-12-28 | Vertex Pharma | Compounds useful as inhibitors of atr kinase |
CN102260264A (zh) * | 2010-05-25 | 2011-11-30 | 浙江海翔药业股份有限公司 | 一种非钯体系制备厄他培南的方法 |
WO2012038979A2 (en) * | 2010-09-24 | 2012-03-29 | Sequent Anti Biotics Private Limited | A process for preparation of ertapenem |
CN102558182B (zh) | 2010-12-31 | 2015-02-11 | 石药集团中奇制药技术(石家庄)有限公司 | 一种厄他培南钠晶型及其制备方法 |
CN102731506B (zh) * | 2011-04-13 | 2015-08-12 | 石药集团中奇制药技术(石家庄)有限公司 | 一种厄他培南及其钠盐的制备方法 |
CN102731502B (zh) * | 2011-04-13 | 2016-08-03 | 石药集团中奇制药技术(石家庄)有限公司 | 一种碳青霉烯抗生素的制备方法 |
CA2850491C (en) | 2011-09-30 | 2020-10-27 | Vertex Pharmaceuticals Incorporated | Treating pancreatic cancer and non-small cell lung cancer with atr inhibiors |
WO2013049726A2 (en) | 2011-09-30 | 2013-04-04 | Vertex Pharmaceuticals Incorporated | Processes for making compounds useful as inhibitors of atr kinase |
US20150038726A1 (en) * | 2012-04-04 | 2015-02-05 | Hospira, Inc. | Process for the preparation of carbapenem antibiotic |
MX358818B (es) | 2012-04-05 | 2018-09-05 | Vertex Pharma | Compuestos utiles como inhibidores de cinasa ataxia telangiectasia mutada y rad3 relacionados (atr) y terapias de combinacion de estos. |
WO2014055756A1 (en) | 2012-10-04 | 2014-04-10 | Vertex Pharmaceuticals Incorporated | Method for measuring atr inhibition mediated increases in dna damage |
KR20150065176A (ko) | 2012-10-12 | 2015-06-12 | 산도즈 아게 | 에르타페넴 중간체의 제조법 |
WO2014087972A1 (ja) * | 2012-12-03 | 2014-06-12 | 株式会社カネカ | 還元型補酵素q10誘導体およびその製造方法 |
US20150361139A1 (en) * | 2013-01-30 | 2015-12-17 | Sandoz Ag | Crystalline form of linaclotide |
TWI637943B (zh) * | 2013-09-05 | 2018-10-11 | 田邊三菱製藥股份有限公司 | 新穎結晶性芳烷基胺化合物及其製造方法 |
IN2013MU03862A (ja) * | 2013-12-11 | 2015-07-31 | Unimark Remedies Ltd | |
CN111888368B (zh) * | 2014-10-21 | 2024-02-02 | 武田药品工业株式会社 | 5-氯-n4-[2-(二甲基磷酰基)苯基]-n2-{2-甲氧基-4-[4-(4-甲基哌嗪-1-基)哌啶-1-基]苯基}嘧啶-2,4-二胺的晶形 |
KR20170014842A (ko) * | 2015-07-31 | 2017-02-08 | 주식회사 대웅제약 | 개선된 에르타페넴 주사제의 제조방법 |
CA3000684A1 (en) | 2015-09-30 | 2017-04-06 | Vertex Pharmaceuticals Incorporated | Method for treating cancer using a combination of dna damaging agents and atr inhibitors |
AU2017208574B2 (en) * | 2016-01-22 | 2022-09-22 | Sandoz Ag | Crystalline eravacycline bis-hydrochloride |
US10889577B2 (en) | 2016-07-07 | 2021-01-12 | Cyclerion Therapeutics, Inc. | Solid forms of an sGC stimulator |
CN110698480B (zh) * | 2018-07-09 | 2023-09-08 | 武汉启瑞药业有限公司 | 一种厄他培南中间体的合成及纯化方法 |
US11186556B1 (en) * | 2018-10-16 | 2021-11-30 | Celgene Corporation | Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof |
CN113416193B (zh) * | 2021-08-23 | 2021-12-17 | 凯莱英医药集团(天津)股份有限公司 | 厄他培南钠新晶型及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1283906C (en) | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF |
IE60588B1 (en) | 1986-07-30 | 1994-07-27 | Sumitomo Pharma | Carbapenem compound in crystalline form, and its production and use |
GB9202298D0 (en) | 1992-02-04 | 1992-03-18 | Ici Plc | Antibiotic compounds |
US5641770A (en) | 1992-12-21 | 1997-06-24 | Chong Kun Dang Corp. | 2-(2-substituted pyrrolidin-4-yl) thio-carbapenem derivatives |
US5648501A (en) | 1995-08-04 | 1997-07-15 | Merck & Co., Inc. | Process for synthesizing carbapenem side chain intermediates |
US6180783B1 (en) | 1997-06-16 | 2001-01-30 | Merck & Co., Inc. | Stabilized carbapenem intermediates and improved process for carbapenem synthesis |
US6063931A (en) | 1997-07-09 | 2000-05-16 | Merck & Co., Inc. | Process for synthesizing carbapenem side chain intermediates |
US5965747A (en) | 1997-07-10 | 1999-10-12 | Merck & Co., Inc. | Crystalline forms of antibiotic side chain intermediates |
US5872250A (en) | 1997-07-30 | 1999-02-16 | Merck & Co., Inc. | Process for synthesizing carbapenem antibiotics |
JP3953274B2 (ja) | 1998-03-02 | 2007-08-08 | メルク エンド カムパニー インコーポレーテッド | カルバペネム抗生物質の合成方法 |
AR035728A1 (es) * | 2001-01-16 | 2004-07-07 | Merck & Co Inc | Proceso perfeccionado para la sintesis de carbapenem |
PL218808B1 (pl) | 2001-09-26 | 2015-01-30 | Merck & Co Inc | Sposób zmniejszania poziomów rozpuszczalników organicznych w stałym karbapenemie |
-
2002
- 2002-09-20 WO PCT/US2002/030002 patent/WO2003026572A2/en active IP Right Grant
- 2002-09-20 US US10/485,319 patent/US7145002B2/en not_active Ceased
- 2002-09-20 AU AU2002331885A patent/AU2002331885B2/en not_active Ceased
- 2002-09-20 CA CA002457642A patent/CA2457642C/en not_active Expired - Lifetime
- 2002-09-20 JP JP2003530211A patent/JP2005508321A/ja active Pending
- 2002-09-20 US US11/999,720 patent/USRE40794E1/en not_active Expired - Lifetime
- 2002-09-20 EP EP02768879A patent/EP1442038A4/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005508321A5 (ja) | ||
AU2006290416B2 (en) | An improved process for the preparation of beta-lactam antibiotic | |
JP2005508321A (ja) | 結晶形態のエルタペネムナトリウム | |
US9233963B2 (en) | Method for preparing meropenem using zinc powder | |
JP5410578B2 (ja) | シラスタチン酸の改善された製造方法 | |
US20110288290A1 (en) | Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem | |
JP6085339B2 (ja) | エルタペネムの中間体、エルタペネムを含む組成物およびそれらの調製方法 | |
JP4098626B2 (ja) | カルバペネムを合成するための改善された方法 | |
US20120035357A1 (en) | Process for the preparation of carbapenem antibiotic | |
US8293924B2 (en) | Process for the preparation of carbapenem antibiotic | |
WO2007029084A2 (en) | A process for the preparation of carbapenem compounds | |
CA2427762C (en) | Process for the preparation of crystalline n-formimidoyl thienamycin monohydrate (imipenem monohydrate) | |
JP5220026B2 (ja) | アルファ−ケトアミドの亜硫酸水素塩精製 | |
ES2328117T3 (es) | Proceso para la preparacion de imipenem. | |
JP2002505331A (ja) | カルバペネム抗生物質の合成方法 | |
JP2011057602A (ja) | 残留パラジウムの除去方法 | |
US20110288289A1 (en) | Preparation of Carbapenem Intermediate and Their Use | |
KR100781821B1 (ko) | 카르바페넴계 화합물의 제조방법 | |
JP2008303143A (ja) | 連続化反応によるカルバぺネム誘導体の製法 | |
US20120253066A1 (en) | Process for the preparation of cilastatin sodium | |
CN102108058B (zh) | 4-aa合成中的环氧丁酰胺的环合反应方法 | |
AU2002302882A1 (en) | Process for the preparation of imipenem | |
JP2009215270A (ja) | 結晶性カルバペネム化合物及びその製造法 | |
JP2011057601A (ja) | カルバペネム化合物の水への安定な溶解方法 | |
WO2000034282A1 (fr) | Derives de 1-methylcarbapenem |